Journal of Peking University(Health Sciences) >
Received date: 2022-08-27
Online published: 2022-12-19
Supported by
National Key Research Development Program of China(201KTCL03_03)
红霞 李 , 雅馨 周 , 亚飞 王 , 鹏宇 王 , 振彪 吴 . [J]. Journal of Peking University(Health Sciences), 2022 , 54(6) : 1229 -1233 . DOI: 10.19723/j.issn.1671-167X.2022.06.029
| 1 | 张文, 厉小梅, 徐东, 等. 原发性干燥综合征诊疗规范[J]. 中华内科杂志, 2020, 59 (4): 269- 270. |
| 2 | Mariette X , Criswell LA . Primary Sj?gren' s syndrome[J]. N Engl J Med, 2018, 378 (10): 931- 939. |
| 3 | Shiboski CH , Shiboski SC , Seror R , et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sj?gren' s syndrome: A consensus and data-driven methodology involving three international patient cohorts[J]. Ann Rheum Dis, 2017, 76 (1): 9- 16. |
| 4 | Seror R , Ravaud P , Bowman SJ , et al. EULAR Sj?gren' s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sj?gren' s syndrome[J]. Ann Rheum Dis, 2010, 69 (6): 1103- 1109. |
| 5 | Vitali C , Bombardieri S , Jonsson R , et al. Classification criteria for Sj?gren' s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61 (6): 554- 558. |
| 6 | Guellec D , Cornec D , Jousse-Joulin S , et al. Diagnostic value of labial minor salivary gland biopsy for Sj?gren' s syndrome: A systematic review[J]. Autoimmun Rev, 2013, 12 (3): 416- 420. |
| 7 | Fisher BA , Jonsson R , Daniels T , et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sj?gren' s syndrome[J]. Ann Rheum Dis, 2017, 76 (7): 1161- 1168. |
| 8 | Retamozo S , Acar-Denizli N , Rasmussen A , et al. Systemic manifestations of primary Sj?gren' s syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients[J]. Clin Exp Rheumatol, 2019, 37 (3/Suppl 118): 97- 106. |
| 9 | Luppi F , Sebastiani M , Silva M , et al. Interstitial lung disease in Sj?gren' s syndrome: A clinical review[J]. Clin Exp Rheumatol, 2020, 38 (4/Suppl 126): 291- 300. |
| 10 | Lin W , Xin Z , Ning X , et al. Clinical features and risk factors of Raynaud' s phenomenon in primary Sj?gren' s syndrome[J]. Clin Rheumatol, 2021, 40 (10): 4081- 4087. |
| 11 | Sharma R , Chaudhari KS , Kurien BT , et al. Sj?gren syndrome without focal lymphocytic infiltration of the salivary glands[J]. J Rheumatol, 2020, 47 (3): 394- 399. |
| 12 | Park Y , Lee J , Koh JH , et al. Positive histopathologic assessment in salivary glands shows little impact on clinical features of established primary Sj?gren' s syndrome in a Korean population[J]. Clin Exp Rheumatol, 2020, 38 (4/ Suppl 126):): 158- 165. |
| 13 | Risselada AP , Kruize AA , Goldschmeding R , et al. The prognostic value of routinely performed minor salivary gland assessments in primary Sj?gren' s syndrome[J]. Ann Rheum Dis, 2014, 73 (8): 1537- 1540. |
| 14 | Kakugawa T , Sakamoto N , Ishimoto H , et al. Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sj?gren' s syndrome[J]. Respir Med, 2018, 137, 95- 102. |
| 15 | Wu S , Tang X , Wu L , et al. Anti-Ro52 antibodies in clinical practice: A single-centre experience[J]. Int J Clin Pract, 2021, 75 (3): e13679. |
/
| 〈 |
|
〉 |